| Filed On | Filing |
|---|---|
| 12 Jun 2017 |
Form 4/A: Apple Robert F, Director
Received 338,115 shares as a grant or award ($899K) |
| 22 Jul 2015 |
Form 4/A: Graham Peter J, SVP General Counsel, Secretary
Granted 125,000 Stock option (right to buy) |
| 17 Jul 2015 |
Form 4/A: Flynn James E, 10% owner and 4 others
Holds 3,388,846 shares of Common Stock |
| 01 Jul 2015 |
Form 4/A: Flynn James E, 10% owner and 5 others
Sold 354,534 shares ($795K) |
| 29 Jun 2015 |
Form 4/A: Hobbs Eamonn P, Director
Granted 293,670 Stock option (right to buy) · Received 245,532 shares as a grant or award |
| 12 Mar 2015 |
Form 4/A: Apple Robert F, Executive Vice President & COO
Gave up 3,526 shares to cover exercise price or tax ($10.5K) · Received 12,519 shares as a grant or award · Gave up 4,779 shares to cover exercise price or tax ($11.3K) |
| 29 Jun 2012 |
Form 4/A: Sadowski Peter L, Former Senior Vice President
Granted 70,000 Stock Option (right to buy) |
| 23 Jul 2004 |
Form 4/A: Garrity Thomas J, Director
Granted 1,250 Option to purchase Antares Pharma, Inc. common stock ($875) |
| 13 May 2004 |
Form 4/A: Xmark Asset Management Llc, 10% owner
Sold 210,000 shares ($210K) |
Loading...